An editorial in the BMJ this week discusses some of the harms associated with selective clinical trial reporting… specifically relating to trials of cardiovascular devices.

To support the points made in the editorial, the author quotes a letter from the AllTrials campaign (a high profile campaign for public registration and reporting of all trial results), which reads:

“The world is moving towards a recognition that hiding information about what was done and what was found in clinical trials is an abuse of trial participants’ trust and exposes patients to unnecessary harm.”